WO2005019381A1 - Liquid crystalline medium - Google Patents
Liquid crystalline medium Download PDFInfo
- Publication number
- WO2005019381A1 WO2005019381A1 PCT/EP2004/008678 EP2004008678W WO2005019381A1 WO 2005019381 A1 WO2005019381 A1 WO 2005019381A1 EP 2004008678 W EP2004008678 W EP 2004008678W WO 2005019381 A1 WO2005019381 A1 WO 2005019381A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- independently
- mono
- carbon atoms
- halogen
- Prior art date
Links
- 0 CC(CC1)COC1c1cc(F)c(*c(cc2F)cc(F)c2F)c(F)c1 Chemical compound CC(CC1)COC1c1cc(F)c(*c(cc2F)cc(F)c2F)c(F)c1 0.000 description 7
- YJXXYDOWRWUZNM-UHFFFAOYSA-N CC(CC1)CC(CC2)C1CC2c(cc1F)cc(F)c1F Chemical compound CC(CC1)CC(CC2)C1CC2c(cc1F)cc(F)c1F YJXXYDOWRWUZNM-UHFFFAOYSA-N 0.000 description 1
- PGXNQWRWIFMVDP-UHFFFAOYSA-N CC(CC1)CCC1C(CC1)CCC1c(cc1)cc(F)c1F Chemical compound CC(CC1)CCC1C(CC1)CCC1c(cc1)cc(F)c1F PGXNQWRWIFMVDP-UHFFFAOYSA-N 0.000 description 1
- FZFRUMHSCFYCBW-UHFFFAOYSA-N CC(CC1)CCC1C(CC1)CCC1c(cc1F)cc(F)c1F Chemical compound CC(CC1)CCC1C(CC1)CCC1c(cc1F)cc(F)c1F FZFRUMHSCFYCBW-UHFFFAOYSA-N 0.000 description 1
- CEXVUEUSQASNGE-UHFFFAOYSA-N CC[C+](c1ccccc1)OC(c(cc1)ccc1-c1ccc(C)cc1)=O Chemical compound CC[C+](c1ccccc1)OC(c(cc1)ccc1-c1ccc(C)cc1)=O CEXVUEUSQASNGE-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/32—Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
- C09K19/322—Compounds containing a naphthalene ring or a completely or partially hydrogenated naphthalene ring
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/32—Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3491—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/42—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/58—Dopants or charge transfer agents
- C09K19/586—Optically active dopants; chiral dopants
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3402—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
- C09K19/3405—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3402—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
- C09K2019/3422—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2323/00—Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
Definitions
- the present invention is related to a liquid crystal medium and the use of said media in electro-optical devices, and especially for the use in electro- optical devices that may be operated in an optically isotropic state.
- Liquid crystals are used generally as dielectrics in display devices, since the optical properties of such substances can be modified by an applied voltage.
- Electro-optical devices based on liquid crystals are extremely well known to the person skilled in the art and can be based on various effects. Examples of such devices are cells having dynamic scattering, DAP (deformation of aligned phases) cells, guest/host cells, TN cells having a twisted nematic structure, STN (supertwisted nematic) cells, SBE (super- birefringence effect) cells and OMI (optical mode interference) cells.
- DAP deformation of aligned phases
- guest/host cells guest/host cells
- TN cells having a twisted nematic structure
- STN (supertwisted nematic) cells SBE (super- birefringence effect) cells
- OMI optical mode interference
- the liquid crystal materials must have good chemical and thermal stability and good stability to electric fields and electromagnetic radiation. Furthermore, the liquid crystal materials should have low viscosity and produce short addressing times, low threshold voltages and high contrast in the cells.
- a suitable mesophase for example a nematic or cholesteric mesophase for the above-mentioned cells, at the usual operating temperatures, i.e. in the broadest possible range above and below room temperature.
- liquid crystals are generally used as mixtures of a plurality of components, it is important that the components are readily miscible with one another.
- Further properties, such as the electrical conductivity, the dielectric anisotropy and the optical anisotropy have to satisfy various requirements depending on the cell type and area of application. For example, materials for cells having a twisted nematic structure should have positive dielectric anisotropy and low electrical conductivity.
- MLC displays matrix liquid crystal displays with integrated non-linear elements for switching individual pixels
- media having large positive dielectric anisotropy, broad nematic phases, relatively low birefringence, very high specific resistance, good UV and temperature stability and low vapour pressure are desired.
- Matrix liquid crystal displays of this type are known.
- Non-linear elements which can be used for individual switching of the individual pixels are, for example, active elements (i.e. transistors).
- active matrix is then used, where a distinction can be made between two types:
- MOS metal oxide semiconductor
- TFTs Thin-film transistors
- the electro- optical effect used is usually the TN effect.
- TFTs comprising compound semiconductors, such as, for example, CdSe, or TFTs based on polycrystalline or amorphous silicon. Intensive work is being carried out world-wide on the latter technology.
- the TFT matrix is applied to the inside of one glass plate of the display, while the other glass plate carries the transparent counterelectrode on its inside. Compared with the size of the pixel electrode, the TFT is very small and has virtually no adverse effect on the image.
- This technology can also be extended to fully colour-capable displays, in which a mosaic of red, green and blue filters is arranged in such a way that a filter element is opposite each switchable pixel.
- the TFT displays usually operate as TN cells with crossed polarisers in transmission and are illuminated from the back.
- MLC displays of this type are particularly suitable for TV applications (for example pocket TVs) or for high-information displays for computer applications (laptops) and in automobile or aircraft construction.
- TV applications for example pocket TVs
- high-information displays for computer applications (laptops) and in automobile or aircraft construction.
- difficulties also arise in MLC displays due to insufficiently high specific resistance of the liquid crystal mixtures [TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORIMACHI, K., TAJIMA, E., WATANABE, H., SH1MIZU, H., Proc. Eurodisplay 84, Sept. 1984: A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, p.
- VHR voltage holding ratio
- the present invention relates to a liquid crystalline mixture consisting of
- a, b, c and d are each independently of each other 0, 1 or 2, whereby a + b + c + d ⁇ 4;
- L 11 , L 12 , L 13 and L 14 are each independently of each other hydrogen, halogen, a CN group, an alkyl or alkoxy radical having from 1 to 15 carbon atoms wherein one or more methylene groups of said alkyl or alkoxy radical may be replaced independently of each other by -O-, -S-,
- R x and R y are each independently of each other hydrogen or an alkyl radical having from 1 to 7 carbon atoms;
- R z is an alkyl radical having from 1 to 7 carbon atoms, said alkyl radical being unsubstituted or mono- or poly-substituted with halogen;
- a 11 , A 12 , A 13 and A 14 are each independently of each other a ring of one of the following formulas:
- a 11 , A 12 , A 13 and A 14 may be the same ring or two different rings if present twice;
- f, g and h are each independently of each other 0, 1 , 2 or 3;
- R 12 has the meaning given for R 11
- a 1 , A 2 , A 3 are each independently of each other
- X 12 is halogen, -CN, -NCS, -SF 5 , -S0 2 CF 3f alkyl, alkenyl, alkenyloxy or alkylalkoxy or alkoxy ratical each mono- or polysubstituted by CN and/or halogen,
- L 1 and L 2 are each independently of each other H or F, and
- n and n are each independently of each other 0, 1 ,or 2 and m + n ⁇ 2;
- component C 1-20 % by weight of component C containing at least one chiral compound with a HTP of ⁇ 20 ⁇ m.
- the compounds of the formula I have a broad range of applications. In the pure state, the compounds of the formula I are colourless and are stable chemically, thermally and to light.
- the compounds according to general formula I do not comprise more than four rings in total, i.e. a + b + c + d ⁇ 3. It is even more preferred that a + b + c + d is at least 1 and not more than 3. Most preferred are compounds according to the invention with a + b + c + d being 2 or 3.
- d 1
- c 0.
- both c and d are equal to 1 , and hence there are two rings A 13 and A 14 present on the right- hand side of the central ring of formula I.
- R 11 is a straight-chain alkyl, alkenyl, alkoxy, alkenyloxy or -O-alkylene-O-alkyl radical or a -0-alkylene-Si(alkyr) 2 -0-Si(alkyF) 3 radical with up to 10 carbon atoms which radicals may be additionally substituted with fluorine whereby alkyl 1 is preferably a straight-chain alkanyl radical with 1, 2, 3 or 4 carbon atoms.
- R 11 is one of the following radicals: C n H 2n+ ⁇ -O- with n being 1 , 2, 3, 4, 5, 6, 7 or 8; C m H 2m - ⁇ -0- with m being 2, 3, 4, 5, 6, 7 or 8; C p H 2 p + ⁇ -0-C q H 2q -0- with p being 1 , 2, 3, 4 or 5 and q being 1 , 2, 3, 4 or 5; (C t H 2 t + ⁇ ) 3 Si-0-Si(CsH 2s+ ⁇ ) 2 -CrH 2 rO- with r being 1 , 2, 3 or 4 and s and t being independently of each other 1 , 2, 3 or 4.
- R 12 is preferably straight chain alkyl with 1 to 6 carbon atoms.
- L 11 is a straight-chain alkyl, alkenyl, alkoxy, alkenyloxy or -O-alkylene-O-alkyl radical or a -0-alkylene-Si(alkyl') 2 -0-Si(alkyF) 3 radical with up to 10 carbon atoms which radicals may be additionally substituted with fluorine whereby alkyl' is preferably a straight-chain alkanyl radical with 1 , 2, 3 or 4 carbon atoms.
- L 11 is one of the following radicals: C n H 2 n + ⁇ -O- with n being 1 , 2, 3, 4, 5, 6, 7 or 8 whereby one or more of the H atoms may be replaced by F; C m H 2 m- ⁇ -0- with m being 2, 3, 4, 5, 6, 7 or 8 whereby one or more of the H atoms may be replaced by F; C p H 2 p + ⁇ -O-C q H 2q -O- with p being 1 , 2, 3, 4 or 5 and q being 1 , 2, 3, 4 or 5; (CtH 2 t + ⁇ ) 3 Si-O-Si(C s H 2s+1 ) 2 -CrH 2r -0- with r being 1 , 2, 3 or 4 and s and t being independently of each other 1 , 2, 3 or 4.
- L 12 is F, a straight-chain alkyl, alkenyl, alkoxy, alkenyloxy or -O-alkylene-O-alkyl radical or a -O-alkylene-Si(alkyl') 2 -O-Si(alkyr) 3 radical with up to 10 carbon atoms which radicals may be additionally substituted with fluorine whereby alkyl' is preferably a straight-chain alkanyl radical with 1 , 2, 3 or 4 carbon atoms.
- L 12 is either F or one of the following radicals: CnH 2 n + rO- with n being 1 , 2, 3, 4, 5, 6, 7 or 8 whereby one or more of the H atoms may be replaced by F; C m H 2 m- O- with m being 2, 3, 4, 5, 6, 7 or 8 whereby one or more of the H atoms may be replaced by F; C p H 2p+1 -O- C q H 2q -0- with p being 1 , 2, 3, 4 or 5 and q being 1 , 2, 3, 4 or 5; (C t H 2 t + i) 3 Si-0-Si(CsH 2s+1 ) 2 -C r H 2r -0- with r being 1 , 2, 3 or 4 and s and t being independently of each other 1 , 2, 3 or 4.
- X 11 is a polar substituent.
- X 11 is -NCS, -SF 5 or -SO 2 -R z , with R z being a straight-chain alkyl radical that is mono- or poly-substituted with fluorine, especially -CF 3 , -C 2 F 5 or n-C 4 F 9 .
- X 11 is also selected from F, Cl, CN, an alkyl, alkenyl or alkoxy radical having up to 8 carbon atoms said alkyl or alkenyl radical being mono- or poly-substituted with fluorine and said alkoxy radical being unsubstituted or mono- or poly-substituted with fluorine.
- a 11 , A 12 , A 13 and A 14 are preferably independently of each other preferably selected from one of the following formulas:
- Y 11 is F, Cl, CN, an alkoxy, alkenyloxy or -O-alkylene-O-alkyl radical or a -0-alkylene-Si(alky ) 2 -0-Si(alkyl') 3 radical with up to 10 carbon atoms which radicals may be additionally substituted with fluorine whereby alkyl' is preferably a straight-chain alkanyl radical with 1 , 2, 3 or 4 carbon atoms. It is still more preferred that Y 11 is one of the following radicals: C n H 2n+ ⁇ - with n being 1 , 2, 3, 4, 5, 6, 7 or 8 whereby one or more of the H atoms may be replaced by F; CmH 2m .
- Y 12 is F, Cl, CN, hydrogen or has the same meaning as the preferred definitions of Y 11 above. Especially, Y 12 is H or F .
- the compounds according to the invention comprise at least one tetrahydropyran-2,5-diyl, naphthyl-2,6-diyl and/or thien-2,5-diyl ring whereby said naphthyl moiety may be substituted with one or more fluorine atoms. It is even more preferred that one of A 11 , A 12 ,
- a 13 and A 14 in formula I is with f and g being independently of each other 0, 1 , 2 or 3; especially, f is 1 and g is 2.
- At least one of A 11 and A 12 and especially A 11 is a tetrahydropyran-2,5-diyl ring.
- at least one of A 13 and A 14 and particularly only one of A 13 and A 14 is of the formula with f and g being independently of each other 0, 1 , 2 or 3. It is highly preferred that f is 1 and g is 2 and the fluorine substituents are located in the 1 -, 3- and 8- position, respectively, of the naphthyl moiety so that all fluorine subtituents have the same orientation as X 11 , i.e. to the right hand of the compound according to formula I.
- one of A 11 aanndd AA 1122 iiss aa tteettrraahhyyddrrooppyyrraann--22,,55--ddiiyyll mmooiieettyy aarnd
- one of A 13 and A 14 is an optionally fluorinated naphtha-2,6-diyl moiety.
- One preferred embodiment of the invention comprises mixtures containing compounds of the formula IA: wherein is 0 or 1 ;
- R 11 is an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly- substituted with halogen; preferably R 11 is a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or mono- or poly- substituted with halogen;
- radical 11 is an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly- substituted with halogen; preferably L 11 is a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or mono- or poly- substituted with halogen;
- _ is hydrogen, halogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen; preferably L 12 is H, F, a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or mono
- L 15 , L 16 , L 17 and L 18 are independently of each other H or F; preferably at least L 15 is F;
- X 11 is F, Cl, CF 3 , OCF 3 , CN, NCS, -SF 5 or -S0 2 -R z ;
- R x and R y are independently of each other hydrogen or an alkyl radical having from 1 to 7 carbon atoms; preferably R x and R y are both methyl, ethyl, propyl or butyl; and
- R 2 is an alkyl radical having from 1 to 7 carbon atoms, said alkyl radical being unsubstituted or mono- or poly-substituted with halogen; preferably R z is CF 3 , C 2 F 5 or n-C 4 F 9 .
- One preferred subgroup of compounds according to formula IA are compounds in which c is zero. Examples of compounds of said subgroup are the following ones:
- n and m are independently of each other integers from 1 to 8, preferably 1 , 2, 3, 4, 5 or 6; p is an integer from 1 to 5, preferably 1 , 2 or 4; q and r are independently of each other integers from 2 to 8, preferably 3, 4, 5, 6; s and t are independently of each other 1 , 2, 3, 4, preferably 2 or 3; and u and v are independently of each other 1 , 2, 3, 4, preferably 1 or 4.
- CnH n + iO and CmH 2 m + ⁇ O represent independently of each other methoxy, ethoxy, propoxy, n-butoxy, n-pentoxy and n-hexoxy.
- both C m H 2m+1 O substituents may have the same value for m or different ones; preferably m in two C m H 2m+ ⁇ O substituents have the same meaning.
- -S0 2 -C p H 2p+ ⁇ represents -SO 2 -CF 3 , -S0 2 -C 2 F 5 , -S0 2 -C 4 F 9 .
- -OC s H 2s OC t H 2 t + ⁇ represents CH 3 OCH 2 CH 2 O- and CH 3 CH 2 OCH 2 CH 2 O-.
- (C v H 2v+ ⁇ ) 3 SiOSi(CuH 2 u + ⁇ )2CsH 2 sO represents (CH 3 ) 3 SiOSi(CH 3 ) 2 CH 2 CH 2 O- and (CH 3 ) 3 SiOSi(CH 3 ) 2 CH 2 CH 2 CH 2 0-.
- Another preferred subgroup of compounds according to formula IA are compounds in which c is 1 .
- Examples of compounds of said subgroup are the following ones:
- L a and L b are independently of each other H or F; n and m are independently of each other integers from 1 to 8, preferably 1 , 2, 3, 4, 5 or 6; p is an integer from 1 to 5, preferably 1 , 2 or 4; q and r are independently of each other integers from 2 to 8, preferably 3, 4, 5, 6; s and t are independently of each other 1 , 2, 3, 4, preferably 2 or 3; and u and v are independently of each other 1 , 2, 3, 4, preferably 1 or 4.
- at least one of L a and L b is F, and especially preferably, both L a and L b are F.
- both C m H 2m+ ⁇ O substituents may have the same value for m or different ones; preferably m in two C m H 2 m + ⁇ O substituents have the same meaning.
- C n H 2n+ ⁇ O and C m H 2m+ ⁇ O represent independently of each other methoxy, ethoxy, propoxy, n-butoxy, n-pentoxy and n-hexoxy.
- -SO 2 - C p H 2p+ ⁇ represents -SO 2 -CF 3 , -SO 2 -C 2 F 5 , -SO 2 -C 4 F 9 .
- -OC s H 2s OCtH 2t+1 represents CH 3 OCH 2 CH 2 O- and CH 3 CH 2 OCH 2 CH 2 O-.
- (CvH 2v+ ⁇ ) 3 SiOSi(CuH 2u+1 ) 2 CsH 2 sO represents (CH 3 ) 3 SiOSi(CH 3 ) 2 CH 2 CH 2 0- and (CH 3 ) 3 SiOSi(CH 3 ) 2 CH2CH 2 CH 2 0-.
- Still another preferred subgroup of compounds according to formula IA are compounds of formula lAc.
- R 11 is an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy radical having from 2 to 15 carbon atoms or an -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen; preferably R 11 is a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted
- L 11 is an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy radical having from 2 to 15 carbon atoms or an -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen; preferably L 11 is a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or
- L 12 is hydrogen, halogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy radical having from 2 to 15 carbon atoms or an -O-alkylene-O-alkyl radical having from 2 to 5 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly- substituted with halogen; preferably L 12 is H, F, a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being
- R 11 , L 11 and L 12 is one of said straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radicals;
- L 15 and L 16 are independently of each other H or F; preferably at least L 15 is F;
- R x and R y are independently of each other hydrogen or an alkyl radical having from 1 to 7 carbon atoms; preferably both R x and R y are methyl, ethyl, propyl or butyl;
- R z is an alkyl radical having from 1 to 7 carbon atoms, said alkyl radical being unsubstituted or mono- or poly-substituted with halogen; preferably R z is CF 3 , C 2 F 5 or n-C F 9 .
- n and m are the same number and equal to 1 , 2, 3, 4, 5 or 6. If present twice in the same compound, both C m H 2m+ ⁇ O substituents may have the same value for m or different ones; preferably m in two C m H 2m+ ⁇ O substituents have the same meaning. Furthermore, one or more of the hydrogen atoms of the C n H 2n+ ⁇ , the OC n H 2n+ ⁇ and the OCmH 2 m + ⁇ moiety, respectively, may be replaced by a halogen atom, preferably a fluorine atom. Particularly preferred are compounds of formulas IB-1 to IB-12 with X 11 being F, CF 3 or OCF 3 , especially F.
- R 11 is an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly- substituted with halogen; preferably R 11 is a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or mono- or poly- substituted with halogen;
- L 11 is an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly- substituted with halogen; preferably, L 11 is a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or mono- or poly- substituted with halogen;
- R 12 is hydrogen, halogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen; preferably, L 12 is H, F, a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or
- R 11 , L 11 and L 12 is one of said preferred straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O- alkyl radicals;
- L 15 , L 16 , L 17 , L 18 and L 19 are independently of each other H or F; preferably at least L 15 and L 8 are both F;
- R x and R y are independently of each other hydrogen or an alkyl radical having from 1 to 7 carbon atoms; preferably both R x and R y are methyl, ethyl, propyl or butyl; and
- R z is an alkyl radical having from 1 to 7 carbon atoms, said alkyl radical being unsubstituted or mono- or poly-substituted with halogen; preferably R z is CF 3 , C 2 F 5 or n-C 4 F 9 .
- both Cr ⁇ H 2m+ ⁇ O substituents may have the same value for m or different ones; preferably in two CmH 2m+ ⁇ O substituents m is the same integer.
- both C q H 2q- ⁇ O substituents may have the same value for q or different ones; preferably in two C q H 2q- ⁇ O substituents q is the same integer.
- n and m are the same number and equal to 1 , 2, 3, 4, 5 or 6.
- one or more of the hydrogen atoms of the C n H 2n+ ⁇ , the OC n H 2n+ i , the OC m H2m + ⁇ and the OC q H 2q - ⁇ moiety, respectively, may be replaced by a halogen atom, preferably a fluorine atom.
- a halogen atom preferably a fluorine atom.
- Particularly preferred are compounds of formulas IC-1 to IC-25 with X 11 being F, CF 3 or OCF 3 , especially F. Examples of said preferred compounds of formula ID are the following ones:
- both C m H 2m+ ⁇ O substituents may have the same value for m or different ones; preferably in two C m H 2m+ ⁇ O substituents m is the same integer.
- both C q H q - ⁇ O substituents may have the same value for q or different ones; preferably in two C q H 2q-1 0 substituents q is the same integer.
- n and m are the same number and equal to 1, 2, 3, 4, 5 or 6.
- one or more of the hydrogen atoms of the C n H 2n+ , the OC n H2n + ⁇ , the OC m H 2m+ ⁇ an the C q H 2q . ⁇ moiety, respectively, may be replaced by a halogen atom, preferably a fluorine atom.
- a halogen atom preferably a fluorine atom.
- Particularly preferred are compounds of formulas ID-1 to ID-60 with X 11 being F, CF 3 or OCF 3 , especially F.
- R 11 is an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly- substituted with halogen; preferably R 11 is a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or mono- or poly- substituted with halogen;
- L 11 is an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly- substituted with halogen; preferably L 11 is a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or mono- or poly- substituted with halogen;
- L 12 is hydrogen, halogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or - O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen; preferably L 12 is H, F, a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or mono
- R 1 ⁇ L 11 and L 12 is one of said straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radicals;
- L 15 , L 16 , L 17 , L 18 , L 19a , L 19b and L 19c are independently of each other H or F; preferably both L 17 and L 19b are F;
- R x and R y are independently of each other hydrogen or an alkyl radical having from 1 to 7 carbon atoms; preferably both R x and R y are methyl, ethyl, propyl or butyl; and;
- R 2 is an alkyl radical having from 1 to 7 carbon atoms, said alkyl radical being unsubstituted or mono- or poly-substituted with halogen; preferably R z is CF 3 , C 2 F 5 or n-C F 9 .
- both C q H 2q -iO substituents may have the same value for q or different ones; preferably in two C q H 2q-1 0 substituents q is the same integer.
- n and m are the same number and equal to 1 , 2, 3, 4, 5 or 6.
- both q and p are the same number and equal to 3, 4, 5, 6.
- one or more of the hydrogen atoms of the C n H 2 ⁇ + ⁇ , the OC ⁇ H 2n+ ⁇ , the OC m H 2m+ ⁇ , the OC p H 2p- ⁇ and the OC q H 2q- ⁇ moiety, respectively, may be replaced by a halogen atom, preferably a fluorine atom.
- Particularly preferred are compounds of formulas IE-1 to IE-36 with X 11 being NCS, SF 5 , S0 2 CF 3 , S0 2 C 2 F 5 , S0 2 C 4 F 9 . Examples of said preferred compounds of formula IF are the following ones:
- both C m H 2m + ⁇ O substituents may have the same value for m or different ones; preferably in two C m H2m+ ⁇ O substituents m is the same integer.
- both C q H 2q- ⁇ O substituents may have the same value for q or different ones; preferably in two C q H 2q - ⁇ O substituents q is the same integer.
- n and m are the same number and equal to 1 , 2, 3, 4, 5 or 6.
- both q and p are the same number and equal to 3, 4, 5, 6.
- one or more of the hydrogen atoms of the C n H 2 ⁇ + ⁇ , the OC n H 2n+ ⁇ , the OC m H 2m+ ⁇ , the OC p H 2p- ⁇ and the OC q H 2q-1 moiety, respectively, may be replaced by a halogen atom, preferably a fluorine atom.
- a halogen atom preferably a fluorine atom.
- Particularly preferred are compounds of formulas IF-1 to IF-72 with X 11 being NCS, SF 5 , S0 2 CF 3 , S0 2 C 2 F 5 , S0 2 C 4 F 9 , F, CF 3 , OCF 3 , especially F.
- R 11 is an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly- substituted with halogen; preferably R 11 is a straight-chain alkyl, alkoxy, alkenyl, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or mono- or poly- substituted with halogen; L 11
- L 12 is hydrogen, halogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced .
- radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen; preferably L 12 is H;
- Y 11 is an alkyl or alkoxy radical having from 1 to 15 carbon atoms or an alkenyl or alkenyloxy or -O-alkylene-O-alkyl radical having from 2 to 15 carbon atoms, wherein one or more methylene groups of each of said radicals may be replaced independently of each other by -S-, -SiR x R y -, -C ⁇ C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly- substituted with halogen; preferably Y 1i is an alkoxy, alkenyloxy or -O-alkylene-O-alkyl radical with up to 10 carbon atoms, said radicals being unsubstituted or mono- or poly-substituted with halogen; in particular Y 11 has the same meaning
- d is 0, 1 or 2; preferably d is 0 or 1 , especially 1 ;
- L 15 and L 16 are independently of each other H or F; preferably both L 15 and L 1 ⁇ are F;
- R x and R y are independently of each other hydrogen or an alkyl radical having from 1 to 7 carbon atoms; preferably both R x and R y are methyl, ethyl, propyl or butyl; and; R z is an alkyl radical having from 1 to 7 carbon atoms, said alkyl radical being unsubstituted or mono- or poly-substituted with halogen; preferably R z is CF 3 , C 2 F 5 or n-C 4 F 9 .
- One preferred subgroup of compounds according to formula IG are compounds of formula I in which d is zero.
- Examples of compounds of said subgroup are the following ones:
- C n H 2n+ ⁇ O, C m H 2m+1 0 and C w H 2w + ⁇ O represent independently of each other methoxy, ethoxy, propoxy, n-butoxy, n- pentoxy and n-hexoxy.
- -OC s H 2 sOCtH 2 t + ⁇ represents CH 3 OCH 2 CH 2 0- and CH 3 CH 2 OCH 2 CH 2 0-.
- (CvH 2 v + ⁇ ) 3 SiOSi(C u H 2 u + ⁇ )2C s H 2 sO represents (CH 3 ) 3 SiOSi(CH 3 )2CH 2 CH 2 0- and (CH 3 ) 3 SiOSi(CH 3 ) 2 CH 2 CH 2 CH 2 0-.
- Particularly preferred are compounds of formulas IGa-1 to IGa-8 with X 11 being F, CF 3 or OCF 3 , especially F.
- Another preferred subgroup of compounds according to formula IG are compounds in which d is 1.
- Examples of compounds of said subgroup are the following ones:
- C n H 2n+ ⁇ O, C m H 2m+1 0 and represent independently of each other methoxy, ethoxy, propoxy, n-butoxy, n- pentoxy and n-hexoxy.
- -OC s H2sOCtH 2 t + ⁇ represents CH 3 OCH 2 CH 2 0- and CH 3 CH 2 OCH 2 CH 0-.
- (C v H 2 v + ⁇ )sSiOSi(C u H 2 u + ⁇ ) 2 CsH 2s O represents (CH 3 ) 3 SiOSi(CH 3 )2CH CH2 ⁇ - and
- the compounds of formula I are partly known from U.S. 6,177,154 or are prepared by methods known per se, as described in the literature (for example in the standard works, such as Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Georg-Thieme- Verlag, Stuttgart), to be precise under reaction conditions which are known and suitable for the said reactions. Use can also be made here of variants which are known per se, but are not mentioned here in greater detail.
- the inventive mixtures contain 1-25 wt.%, preferably 2-20 wt.% and most preferably 3-15 wt.% of component A.
- Preferred compounds of component B are compounds of the formulae 11-1 to il-8:
- X is preferably F, CN, NCS, CF 3 , SF S or OCF 3 .
- R 12 is preferably straight chain alkyl or alkoxy with up to six carbon atoms. Especially preferred are compounds of the formulae II-5 and II-8.
- the inventive mixtures contain 20-80 wt.% of the pyrane compounds of the formulae II, preferably 25-70 wt.% and especially preferred 30-60 wt.%.
- Suitable chiral compounds of component C are those which have a helical twisting power of > 20 ⁇ m, preferably > 40 ⁇ m, most preferably > 60 ⁇ m.
- the HTP is measured in MLC 6260.
- the chiral component C comprises one or more chiral compounds which have a mesogenic structure und exhibit preferably one or more mesophases themselves, particularly at least one cholesteric phase.
- Preferred chiral compounds being comprised in the chiral component C are, inter alia, well known chiral dopants like cholesteryl nonanoate (CN), R/S-811 , R/S-1011 , R/S-2011 , R/S-3011 , R/S-4011 , R/S-5011 , CB-15 (Merck KGaA, Darmstadt, Germany).
- chiral dopants having one or more chiral moieties and one or more mesogenic groups or having one or more aromatic or alicyclic moieties forming, together with the chiral moiety, a mesogenic group. More preferred are chiral moieties and mesogenic chiral compounds disclosed in DE 3425 503, DE 35 34 777, DE 35 34 778, DE 35 34 779, DE 35 34 780, DE 43 42 280, EP 01 038941 and DE 19541 820 that disclosure is incorporated herewithin by way of reference.
- chiral binaphthyl derivatives as disclosed in EP 01 111 954.2, chiral binaphtnol derivatives as disclosed in WO 02/34739, chiral TADDOL derivatives as disclosed in WO 02/06265 as well as chiral dopants having at least one fluorinated linker and one end chiral moiety or one central chiral moiety as disclosed in WO 02/06196 and WO 02/06195.
- the controlling medium of the present invention has a characteristic temperature, preferably a clearing point, in the range from about -30 °C to about 80 °C, especially up to about 55 °C.
- Preferred chiral compounds of the component C are selected from the group of the compounds C-l to C-lll.
- pa11 pa12 are each independently from each other alkyl, oxalkyl, p,a21 pa22 alkoxy or alkenyl with up 9 carbon atoms with the R a31 and R a32 provisos that a) R a11 + R a12 b) R a21 + R a22
- R a1 ⁇ R a12 , R a21 , R a22 , R a31 and R a32 are an alkyl group, especially a straight chain alkyl group.
- binaphthyl derivatives of the formulae C-IV-1a to IC-IV-1C are especially preferred.
- R' 0* is hydrogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms wherein one or more methylene groups of said alkyl or alkoxy radical may be replaced independetly of each other by -0-.
- -S-, -SiR x R Y -, -CH CH-, -C ⁇ C-, -CO-O- and/or -O-CI- such that oxygen and/or sulfur atoms are not linked directly to each other, said alkyl or alkoxy radical being unsubstituted or mon- or poly-substituted with halogen,
- the inventive mixtures contain one ore more (two, three, four or more) chiral compounds in the range of 1-25 wt.%, preferably 2-20 wt.%. Especially preferred are mixtures containing 3-15 wt.% of a chiral compound.
- the medium comprises one, two or more compounds of the formulae
- Componend B preferably contains beside at compounds of the formula II at least one or more ester compounds of the formula Z
- X ⁇ is F, Cl, CN, NCS, OCF 3 , CF 3 or SF 5 .
- Preferred compounds of the formula Z are
- the component B contains additionally one or more compounds selected from the group
- the medium component B additionally comprises one or more compounds selected from the group consisting of the general formulae III to VII:
- R° is n-alkyl, alkoxy, oxaalkyl, fluoroalkyl or alkenyl, each having up to 9 carbon atoms,
- X° is CN, SF5, NCS, SO 2 CF 3 , F, Cl, halogenated alkyl, halogenated alkenyl, halogenated alkenyloxy or halogenated alkoxy having up to 6 carbon atoms,
- Y 1 to Y 4 are each, independently of one another, H or F, r is 0 or 1.
- the compound of the formula V is preferably
- the component B additionally comprises one or more compounds selected from the group consisting of the general formulae VIII to XV:
- R°, X° and Y 1"4 are each, independently of one another, as defined in Claim 3.
- X° is preferably F, Cl, CF 3 , OCF 3 or OCHF 2 .
- R° is preferably alkyl, oxaalkyl, fluoroalkyl or alkenyl, each having up to 6 carbon atoms.
- the component B additionally comprises one or more compounds of the formulae E-a to E-d
- the proportion of the compounds of the formulae E-a to E-d is preferably 10-30% by weight, in particular 15-25% by weight;
- the proportion of compounds of the formulae II to VII in the mixture as a whole is from 1 to 30 weight;
- the medium comprises compounds of the formulae II, III, IV, V and/or VI;
- R° is straight-chain alkyl or alkenyl having from 2 to 7 carbon atoms;
- Component B comprises further compounds, preferably selected from the following group consisting of the general formulae XVI to XX:
- the 1 ,4-phenylene rings may additionally be substituted by CN, chlorine or fluorine.
- the 1 ,4- phenylene rings are preferably monosubstituted or polysubstituted by fluorine atoms.
- Liquid crystalline medium additionally comprises one, two, three or more, preferably two or three, compounds of the formulae
- the medium preferably comprises one, two or three compounds of the formula IVa in which X° is F or OCF 3 .
- the medium preferably comprises one or more compounds of the formulae lla to llg
- R° is as defined above.
- R° is preferably methyl, ethyl, n-propyl, n-butyl or n-pentyl.
- the medium preferably comprises one or more compounds of the formulae
- the proportion of the compounds of the formula IVb and/or IVc in which X° is fluorine and R° is CH 3 , C 2 H 5 , n-C 3 H , n-C H 9 or n-C 5 Hn in the mixture as a whole is from 2 to 20% by weight, in particular from 2 to 15% by weight.
- the medium preferably comprises compounds of the formulae II to VI in which R° is methyl.
- the medium particularly preferably comprises compounds of the formulae
- the medium preferably comprises one, two or more, preferably one or two, dioxane compounds of the formulae
- the medium additionally comprises one, two or more bicyclic compounds of the formulae Z1 to Z6 alkyl* Z-1
- R 1a and R 2a are each, independently of one another, H, CH 3 , C 2 H 5 or n-C 3 H 7 .
- R°, alkyl and alkyl* are as defined in Claim 3 or as defined below.
- the medium additionally comprises one, two or more compounds having fused rings, of the formulae AN 1 to AN11 : in which R° is as defined above.
- alkyl or "alkyl*” covers straight-chain and branched alkyl groups having 1-7 carbon atoms, in particular the straight-chain groups methyl, ethyl, propyl, butyl, pentyl, hexyl and heptyl. Groups having 1-5 carbon atoms are generally preferred.
- alkenyl covers straight-chain and branched alkenyl groups having 2-7 carbon atoms, in particular the straight-chain groups.
- Preferred alkenyl groups are C 2 -C 7 -1 E-alkenyl, C 4 -C 7 -3E-alkenyl, C 5 -C 7 -4-alkenyl, C 6 -C7-5-alkeny) and C 7 -6-alkenyl, in particular C 2 -C -1E-alkenyl, C -C 7 -3E- alkenyl and Cs-C -4-alkenyl.
- alkenyl groups are vinyl, 1E-propenyl, 1E-butenyl, 1E-pentenyl, 1E-hexenyl, 1 E-heptenyl, 3-butenyl, 3E-pentenyl, 3E-hexenyl, 3E-heptenyl, 4-pentenyl, 4Z-hexenyl, 4E-hexenyl, 4Z-heptenyl, 5-hexenyl, 6-heptenyl and the like. Groups having up to 5 carbon atoms are generally preferred.
- fluoroalkyl preferably covers straight-chain groups having a terminal fluorine, i.e. fluoromethyl, 2-fluoroethyl, 3-fluoropropyl, 4-fluoro- butyl, 5-fluoropentyl, 6-fluorohexyl and 7-fluoroheptyl.
- fluorine i.e. fluoromethyl, 2-fluoroethyl, 3-fluoropropyl, 4-fluoro- butyl, 5-fluoropentyl, 6-fluorohexyl and 7-fluoroheptyl.
- other positions of the fluorine are not excluded.
- oxaalkyl preferably covers straight-chain radicals of the formula C n H 2n + ⁇ -O-(CH 2 )m, in which n and m are each, independently of one another, from 1 to 6.
- the optimum mixing ratio of the compounds of the formulae I and II + III + IV + V + VI + VII depends substantially on the desired properties, on the choice of the components of the formulae III, IV, V, VI and/or VII, and on the choice of any other components that may be present. Suitable mixing ratios within the range given above can easily be determined from case to case.
- the total amount of compounds of the formulae I to XV in the mixtures according to the invention is not crucial.
- the mixtures can therefore comprise one or more further components for the purposes of optimisation of various properties.
- the observed effect on the operating voltage and the operating temperature range is generally greater, the higher the total concentration of compounds of the formulae I to XV.
- the construction of the MLC display according to the invention from polarisers, electrode base plates and surface-treated electrodes corresponds to the conventional construction for displays of this type.
- the term conventional construction is broadly drawn here and also covers all derivatives and modifications of the MLC display, in particular including matrix display elements based on poly-Si TFT or MIM.
- a significant difference between the displays according to the invention and the conventional displays based on the twisted nematic cell consists, however, in the choice of the liquid-crystal parameters of the liquid-crystal layer.
- the media according to the invention are prepared in a manner conventional per se.
- the components are dissolved in one another, advantageously at elevated temperature.
- the liquid-crystalline phases in accordance with the invention can be modified in such a way that they can be used in all types of liquid crystal display elements that have been disclosed hitherto. Additives of this type are known to the person skilled in the art and are described in detail in the literature (H. Kelker/R. Hatz, Handbook of Liquid Crystals, Veriag Chemie, Weinheim, 1980).
- pleochroic dyes can be added for the pre- paration of coloured guest-host systems or substances can be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases.
- stabilisers and antioxidants can be added.
- the mixtures according to the invention are suitable for TN, STN, ECB and IPS applications and isotropic switching mode (ISM) applications.
- ISM isotropic switching mode
- the inventive mixtures are highly suitable for devices which operate in an optically isotropic state.
- the mixtures of the invention are surprisingly found to be highly suitable for the respective use.
- Electro-optical devices that are operated or operable in an optically isotropic state recently have become of interest with respect to video, TV, and multi-media applications. This is because conventional liquid crystal displays utilizing electro-optical effects based on the physical properties of liquid crystals exhibit a rather high switching time which is undesired for said applications. Furthermore most of the conventional displays show a significant viewing angle dependence of contrast that in turn makes necessary measures to compensate this undesired property.
- German Patent Application DE 102 17 273 A1 discloses light controlling (light modulation) elements in which the mesogenic controlling medium for modulation is in the isotropic phase at the operating temperature.
- These light controlling elements have a very short switching time and a good viewing angle dependence of contrast.
- the driving or operating voltages of said elements are very often unsuitably high for some applicatons.
- German Patent Application DE 102 41 301 yet unpublished describes specific structures of electrodes allowing a significant reduction of the driving voltages. However, these electrodes make the process of manufacturing the light controlling elements more complicated.
- the light controlling elements for example, disclosed in both DE 102 17 273 A1 and DE 102 41 301 show a significant temperature dependence.
- the electro-optical effect that can be induced by the electrical field in the controlling medium being in an optical isotropic state is most pronounced at temperatures close to the clearing point of the controlling medium.
- the light controlling elements have the lowest values of their characteristic voltages and, thus, require the lowest operating voltages.
- Typical values of the temperature dependence are in the range from about a few volts per centigrade up to about ten or more volts per centigrade.
- DE 102 41 301 describes various structures of electrodes for devices operable or operated in the isotropic state
- DE 102 17 273 A1 discloses isotropic media of varying composition that are useful in light controlling elements operable or operated in the isotropic state.
- the relative temperature dependence of the threshold voltage in these light controlling elements is at a temperature of 1 centigrade above the clearing point in the range of about 50%/centigrade. That temperature dependence decreases with increasing temperature so that it is at a temperature of 5 centigrade above the clearing point of about 10%/centigrade.
- the temperature dependence of the electro-optical effect is too high.
- the operating voltages are independent from the operating temperature over a temperature range of at least some centigrades, preferably of about 5 centigrades or more, even more preferably of about 10 centigrades or more and especially of about 20 centigrades or more.
- inventive mixtures are highly suitable as controlling media in the light controlling elements as described above and in DE 102 17 273 A1 , DE 102 41 301 and DE 102 536 06 and broaden the temperature range in which the operating voltages of said electro-optical operates.
- the optical isotropic state or the blue phase is almost completely or completely independent from the operating temperature.
- Liquid crystals having an extremely high chiral twist may have one or more optically isotropic phases. If they have a respective cholesteric pitch, these phases might appear bluish in a cell having a sufficiently large cell gap. Those phases are therefore also called “blue phases” (Gray and Goodby, “Smectic Liquid Crystals, Textures and Structures", Leonhard Hill, USA, Canada (1984)). Effects of electrical fields on liquid crystals existing in a blue phase are described for instance in H.S. Kitzerow, "The Effect of Electric Fields on Blue Phases", Mol. Cryst. Liq.
- inventive mixtures can be used in an electro-optical light controlling element which comprises one or more, especially two substrates; an assembly of electrodes; one or more elements for polarizing the light; and said controlling medium;
- said light controlling element is operated (or operable) at a temperature at which the controlling medium is in an optically isotropic phase when it is in a non-driven state.
- the controlling medium of the present invention has a characteristic temperature, preferably a clearing point, in the range from about -30 °C to about 80 °C, especially up to about 55 °C.
- the operating temperature of the light controlling elements is preferably above the characteristic temperature of the controlling medium said temperature being usually the transition temperature of the controlling medium to the blue phase; generally the operating temperature is in the range of about 0.1 ° to about 50 °, preferably in the range of about 0.1 ° to about 10 ° above said characteristic temperature. It is highly preferred that the operating temperature is in the range from the transition temperature of the controlling medium to the blue phase up to the transition temperature of the controlling medium to the isotropic phase which is the clearing point.
- the light controlling elements may also be operated at temperatures at which the controlling medium is in the isotropic phase.
- characteristic temperature is defined as follows:
- characteristic temperature the temperature at this minimum is denoted as characteristic temperature.
- the transistion temperature to the blue phase is denoted as characteristic temperature; in case there are more than one blue phase, the lowest transition temperature to a blue phase is denoted as characteristic temperature.
- characteristic temperature If the characteristic voltage as a function of temperature has no minimum and if the controlling medium has no blue phase, the transistion temperature to the isotropic phase is denoted as characteristic temperature.
- alkyl means - as long as it is not defined in a different manner elsewhere in this description or in the claims - straight-chain and branched hydrocarbon (aliphatic) radicals with 1 to 15 carbon atoms.
- the hydrocarbon radicals may be unsubstituted or substituted with one or more substituents being independently selected from the group consisting of F, Cl, Br, I or CN.
- the dielectrics may also comprise further additives known to the person skilled in the art and described in the literature. For example, 0-15% of pleochroic dyes, antioxidants or stabilizers can be added.
- C denotes a crystalline phase
- S a smectic phase Sc a smectic C phase
- N a nematic phase
- I the isotropic phase
- BP the blue phase.
- V-io denotes the voltage for 10% transmission
- V100 denotes the voltage for 100% transmission (viewing angle perpendicular to the plate surface).
- t on denotes the switch-on time and t off the switch-off time at an operating voltage corresponding the value of V100.
- ⁇ n denotes the optical anisotropy.
- the electro-optical data are measured in a TN cell at the 1 st minimum (i.e. at a d • ⁇ n value of 0.5 ⁇ m) at 20°C, unless expressly stated otherwise.
- the optical data are measured at 20°C, unless expressly stated otherwise.
- liquid-crystalline mixtures which, besides the compounds of the formula I, comprise at least one, two, three or four compounds from Table B.
- Table C shows possible dopants according to component C which are generally added to the mixtures alone or in combination two, three or more) according to the invention.
- Stabilisers which can be added, for example, to the mixtures according to the invention are mentioned below.
- the medium is introduced into a test cell with interdigital electrodes on one substrate only.
- the thickness of the mesogenic layer in the cell is 10 ⁇ m and the distance between the electrodes is 10 ⁇ m, the electrode width is 10 ⁇ m.
- ⁇ n denotes optical anisotropy (589 nm, 20°C).
- the flow viscosity v 2 o (mm2/sec) and the rotational viscosity ⁇ -i (mPa-s) were each determined at 20°C.
- the physical data illustrate which properties can be achieved in which ranges.
- the "usable range” is determined by switching times being smaller than 5 msec within this temperature range.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE602004012873T DE602004012873T2 (en) | 2003-08-25 | 2004-08-03 | LIQUID CRYSTALLINE MEDIUM |
EP04741358A EP1658352B1 (en) | 2003-08-25 | 2004-08-03 | Liquid crystalline medium |
JP2006524258A JP4949027B2 (en) | 2003-08-25 | 2004-08-03 | Liquid crystal media |
KR1020067003874A KR101198479B1 (en) | 2003-08-25 | 2004-08-03 | Liquid crystalline medium |
US10/569,460 US7419706B2 (en) | 2003-08-25 | 2004-08-03 | Liquid crystalline medium |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03018709.0 | 2003-08-25 | ||
EP03018709 | 2003-08-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005019381A1 true WO2005019381A1 (en) | 2005-03-03 |
Family
ID=34203218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/008678 WO2005019381A1 (en) | 2003-08-25 | 2004-08-03 | Liquid crystalline medium |
Country Status (8)
Country | Link |
---|---|
US (1) | US7419706B2 (en) |
EP (1) | EP1658352B1 (en) |
JP (1) | JP4949027B2 (en) |
KR (1) | KR101198479B1 (en) |
AT (1) | ATE391161T1 (en) |
DE (1) | DE602004012873T2 (en) |
TW (1) | TWI362412B (en) |
WO (1) | WO2005019381A1 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008095097A (en) * | 2006-10-04 | 2008-04-24 | Merck Patent Gmbh | Liquid crystal medium |
WO2008105286A1 (en) | 2007-02-28 | 2008-09-04 | Chisso Corporation | Pentacyclic liquid crystal compound having cf2o bonding group, liquid crystal composition and liquid crystal display |
JP2008545667A (en) * | 2005-05-25 | 2008-12-18 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Process for the preparation of 2,5-2 substituted tetrahydropyran derivatives by reductive elimination of the corresponding 4-halogen derivatives |
JP2008545668A (en) * | 2005-05-25 | 2008-12-18 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Process for the preparation of tetrahydropyran derivatives |
WO2009150963A1 (en) | 2008-06-09 | 2009-12-17 | チッソ株式会社 | Pentacyclic liquid crystal compound having cyclohexane ring, liquid crystal composition and liquid crystal display element |
WO2010047260A1 (en) | 2008-10-21 | 2010-04-29 | チッソ株式会社 | Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element |
US7785675B2 (en) * | 2005-06-09 | 2010-08-31 | Adeka Corporation | Compound and liquid crystal composition |
US7834037B2 (en) | 2005-11-04 | 2010-11-16 | Amira Pharmaceuticals, Inc. | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
US8003175B2 (en) | 2008-06-24 | 2011-08-23 | Jnc Corporation | Liquid crystal composition and liquid crystal display device |
US8110256B2 (en) | 2008-06-25 | 2012-02-07 | Jnc Corporation | Liquid crystal composition and liquid crystal display device |
US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US8546431B2 (en) | 2008-10-01 | 2013-10-01 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US8697730B2 (en) | 2007-10-26 | 2014-04-15 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase activating protein (FLAP) inhibitor |
US8772495B2 (en) | 2008-05-23 | 2014-07-08 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein inhibitor |
WO2022117551A1 (en) | 2020-12-02 | 2022-06-09 | Merck Patent Gmbh | Liquid crystalline medium and electro-optical device |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007503405A (en) * | 2003-08-25 | 2007-02-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Compounds for use in liquid crystal media |
KR101503953B1 (en) * | 2007-08-27 | 2015-03-18 | 제이엔씨 석유 화학 주식회사 | Liquid crystal composition, and liquid crystal display element |
CN101790575B (en) * | 2007-08-29 | 2013-01-23 | Jnc株式会社 | Liquid crystal composition and liquid crystal display element |
US7879413B2 (en) * | 2007-08-29 | 2011-02-01 | Chisso Corporation | Optically isotropic liquid crystal medium and optical device |
JP5470757B2 (en) * | 2007-08-29 | 2014-04-16 | Jnc株式会社 | Optically isotropic liquid crystal medium and optical element |
CN101772560B (en) | 2007-08-30 | 2013-03-13 | Jnc株式会社 | Liquid crystal composition, and liquid crystal display element |
US8153021B2 (en) * | 2007-08-31 | 2012-04-10 | Jnc Corporation | Liquid crystal composition and liquid crystal display device |
DE102011122559A1 (en) * | 2011-01-25 | 2012-07-26 | Merck Patent Gmbh | Liquid crystalline compounds and liquid crystalline media |
DE102012003876A1 (en) * | 2011-03-24 | 2012-09-27 | Merck Patent Gmbh | Compound with a C-C triple bond |
JP5776864B1 (en) | 2013-08-30 | 2015-09-09 | Dic株式会社 | Nematic liquid crystal composition |
CN106459767B (en) | 2014-07-31 | 2019-04-19 | Dic株式会社 | Nematic liquid crystal composition |
JP5910800B1 (en) | 2014-07-31 | 2016-04-27 | Dic株式会社 | Nematic liquid crystal composition |
CN108130101B (en) * | 2014-11-20 | 2021-05-25 | 北京八亿时空液晶科技股份有限公司 | Liquid crystal compound containing difluoromethoxy bridge bond and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6177154B1 (en) * | 1996-09-17 | 2001-01-23 | Chisso Corporation | Alkoxybenzene derivative, liquid-crystal composition, and liquid-crystal display element |
EP1182186A2 (en) * | 2000-08-10 | 2002-02-27 | Chisso Corporation | Difluoromethyl ether derivative and process for producing the same |
DE10217273A1 (en) * | 2001-05-16 | 2002-12-05 | Merck Patent Gmbh | Electro-optical light control element, for use in display systems e.g. television and computer screens, is operated at a temperature at which the mesogenic control medium is in the isotropic phase |
DE10241301A1 (en) * | 2002-09-04 | 2004-03-18 | Merck Patent Gmbh | Electrooptic light control element and display and medium for television and computer screens has temperature driven control mechanism |
WO2004048501A1 (en) * | 2002-11-27 | 2004-06-10 | Merck Patent Gmbh | Liquid crystalline compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10204790A1 (en) * | 2002-02-06 | 2003-08-14 | Merck Patent Gmbh | Liquid crystalline medium |
DE50307287D1 (en) * | 2002-09-30 | 2007-06-28 | Merck Patent Gmbh | Liquid crystalline medium |
DE10359469A1 (en) * | 2002-12-21 | 2004-07-08 | Merck Patent Gmbh | New fluorinated pyran liquid crystalline compounds are useful for liquid crystal media for optoelectronic applications including twisted nematic, super twisted nematic and in-plane switching |
DE102004056901B4 (en) * | 2003-12-17 | 2014-01-09 | Merck Patent Gmbh | Liquid-crystalline medium and its use |
DE102004058002B4 (en) * | 2003-12-17 | 2014-01-09 | Merck Patent Gmbh | Liquid-crystalline medium and its use |
-
2004
- 2004-08-03 WO PCT/EP2004/008678 patent/WO2005019381A1/en active IP Right Grant
- 2004-08-03 DE DE602004012873T patent/DE602004012873T2/en active Active
- 2004-08-03 KR KR1020067003874A patent/KR101198479B1/en not_active IP Right Cessation
- 2004-08-03 EP EP04741358A patent/EP1658352B1/en not_active Not-in-force
- 2004-08-03 US US10/569,460 patent/US7419706B2/en not_active Expired - Fee Related
- 2004-08-03 AT AT04741358T patent/ATE391161T1/en not_active IP Right Cessation
- 2004-08-03 JP JP2006524258A patent/JP4949027B2/en not_active Expired - Fee Related
- 2004-08-26 TW TW093125609A patent/TWI362412B/en not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6177154B1 (en) * | 1996-09-17 | 2001-01-23 | Chisso Corporation | Alkoxybenzene derivative, liquid-crystal composition, and liquid-crystal display element |
EP1182186A2 (en) * | 2000-08-10 | 2002-02-27 | Chisso Corporation | Difluoromethyl ether derivative and process for producing the same |
DE10217273A1 (en) * | 2001-05-16 | 2002-12-05 | Merck Patent Gmbh | Electro-optical light control element, for use in display systems e.g. television and computer screens, is operated at a temperature at which the mesogenic control medium is in the isotropic phase |
DE10241301A1 (en) * | 2002-09-04 | 2004-03-18 | Merck Patent Gmbh | Electrooptic light control element and display and medium for television and computer screens has temperature driven control mechanism |
WO2004048501A1 (en) * | 2002-11-27 | 2004-06-10 | Merck Patent Gmbh | Liquid crystalline compounds |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008545667A (en) * | 2005-05-25 | 2008-12-18 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Process for the preparation of 2,5-2 substituted tetrahydropyran derivatives by reductive elimination of the corresponding 4-halogen derivatives |
JP2008545668A (en) * | 2005-05-25 | 2008-12-18 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Process for the preparation of tetrahydropyran derivatives |
US7785675B2 (en) * | 2005-06-09 | 2010-08-31 | Adeka Corporation | Compound and liquid crystal composition |
US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US8841295B2 (en) | 2005-11-04 | 2014-09-23 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US7834037B2 (en) | 2005-11-04 | 2010-11-16 | Amira Pharmaceuticals, Inc. | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US8710081B2 (en) | 2005-11-04 | 2014-04-29 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
JP2008095097A (en) * | 2006-10-04 | 2008-04-24 | Merck Patent Gmbh | Liquid crystal medium |
US7951433B2 (en) | 2007-02-28 | 2011-05-31 | Chisso Corporation | Five-ring liquid crystal compound having CF2O bonding group, liquid crystal composition, and liquid crystal display device |
WO2008105286A1 (en) | 2007-02-28 | 2008-09-04 | Chisso Corporation | Pentacyclic liquid crystal compound having cf2o bonding group, liquid crystal composition and liquid crystal display |
US8697730B2 (en) | 2007-10-26 | 2014-04-15 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase activating protein (FLAP) inhibitor |
US8772495B2 (en) | 2008-05-23 | 2014-07-08 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein inhibitor |
WO2009150963A1 (en) | 2008-06-09 | 2009-12-17 | チッソ株式会社 | Pentacyclic liquid crystal compound having cyclohexane ring, liquid crystal composition and liquid crystal display element |
US8003175B2 (en) | 2008-06-24 | 2011-08-23 | Jnc Corporation | Liquid crystal composition and liquid crystal display device |
US8110256B2 (en) | 2008-06-25 | 2012-02-07 | Jnc Corporation | Liquid crystal composition and liquid crystal display device |
US8546431B2 (en) | 2008-10-01 | 2013-10-01 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
CN102186821A (en) * | 2008-10-21 | 2011-09-14 | Jnc株式会社 | Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element |
CN102186821B (en) * | 2008-10-21 | 2014-06-25 | Jnc株式会社 | Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element |
KR20110070988A (en) | 2008-10-21 | 2011-06-27 | 제이엔씨 주식회사 | Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element |
WO2010047260A1 (en) | 2008-10-21 | 2010-04-29 | チッソ株式会社 | Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element |
WO2022117551A1 (en) | 2020-12-02 | 2022-06-09 | Merck Patent Gmbh | Liquid crystalline medium and electro-optical device |
Also Published As
Publication number | Publication date |
---|---|
ATE391161T1 (en) | 2008-04-15 |
TWI362412B (en) | 2012-04-21 |
EP1658352B1 (en) | 2008-04-02 |
JP4949027B2 (en) | 2012-06-06 |
DE602004012873T2 (en) | 2009-08-20 |
EP1658352A1 (en) | 2006-05-24 |
US20060210724A1 (en) | 2006-09-21 |
KR20060069471A (en) | 2006-06-21 |
KR101198479B1 (en) | 2012-11-06 |
JP2007503485A (en) | 2007-02-22 |
US7419706B2 (en) | 2008-09-02 |
DE602004012873D1 (en) | 2008-05-15 |
TW200521211A (en) | 2005-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1658352B1 (en) | Liquid crystalline medium | |
EP3228681B1 (en) | Liquid-crystalline medium and liquid-crystal display comprising the same | |
KR102512438B1 (en) | Liquid crystal medium and liquid crystal display including the same | |
KR101617475B1 (en) | Liquid-crystalline medium | |
TWI381038B (en) | Liquid-crystalline medium | |
TWI464243B (en) | Liquid-crystalline medium | |
KR101546970B1 (en) | Stilbene derivatives liquid-crystal mixtures and electro-optical displays | |
EP1454975B1 (en) | Liquid crystalline medium | |
WO2010017868A1 (en) | Liquid-crystalline medium | |
WO2009156118A1 (en) | Liquid-crystalline medium | |
TWI421331B (en) | Liquid-crystalline medium | |
US20040238789A1 (en) | Liquid crystal compounds | |
EP3421570A1 (en) | Liquid-crystalline medium and liquid-crystal display comprising the same | |
WO2006133783A1 (en) | Liquid-crystalline medium and liquid crystal display with 1,2-difluoroethene compounds | |
EP1658350A1 (en) | Compounds for use in liquid crystal media | |
EP1762605B1 (en) | Naphthalene compound with terminal hydrogen, liquid crystal composition including the compound, and LCD device including the liquid crystal composition | |
EP2144975A1 (en) | Liquid- crystalline medium | |
TWI596195B (en) | Liquid-crystalline medium | |
KR20130073911A (en) | Liquid-crystalline medium | |
GB2516189A (en) | Liquid-crystalline medium | |
WO2005112540A2 (en) | Liquid crystal compounds, liquid crystal medium and liquid crystal display | |
EP2041238B1 (en) | Liquid crystalline medium | |
KR20220028108A (en) | Liquid-crystal media, liquid-crystal displays comprising same, and compounds | |
TW202033750A (en) | Liquid-crystalline medium and liquid-crystal display comprising the same and compounds | |
WO2005095544A1 (en) | Liquid crystal compounds, liquid crystal medium and liquid crystal display |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004741358 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006524258 Country of ref document: JP Ref document number: 1020067003874 Country of ref document: KR Ref document number: 10569460 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2004741358 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067003874 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10569460 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2004741358 Country of ref document: EP |